Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite
Listen now
Description
Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). Credit available for this activity expires: 7/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001303?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation. Credit available for this activity expires: 10/29/25 Earn Credit / Learning Objectives & Disclosures:...
Published 10/29/24
Published 10/29/24
Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD). Credit available for this activity expires: 10/28/25 Earn Credit / Learning Objectives & Disclosures: ...
Published 10/29/24